Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-12-037312
Filing Date
2012-06-29
Accepted
2012-06-29 16:03:22
Documents
5
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v316641_10k.htm 10-K 1624196
2 EXHIBIT 31.1 v316641_ex31-1.htm EX-31.1 9538
3 EXHIBIT 31.2 v316641_ex31-2.htm EX-31.2 9891
4 EXHIBIT 32.1 v316641_ex32-1.htm EX-32.1 4858
5 EXHIBIT 32.2 v316641_ex32-2.htm EX-32.2 4850
  Complete submission text file 0001144204-12-037312.txt   1654529
Mailing Address 2492 WALNUT AVENUE STE 100 TUSTIN CA 92780
Business Address 2492 WALNUT AVENUE STE 100 TUSTIN CA 92780 7145054460
RADIENT PHARMACEUTICALS Corp (Filer) CIK: 0000838879 (see all company filings)

EIN.: 330413161 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16695 | Film No.: 12936089
SIC: 2834 Pharmaceutical Preparations